FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Fund ProfileF/M Emerald Life Sciences Innovation ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
LFSC
F/M Emerald Life Sciences Innovation ETF ETF AnalysisComprehensive ETF analysis for F/M Emerald Life Sciences Innovation ETF (LFSC) including NAV, expense ratio, dividend yield, sector breakdown, and holdings data.ETF AnalysisLFSC
LFSC
F/M Emerald Life Sciences Innovation ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
LFSC
  1. Home
  2. Screener
  3. F/M Emerald Life Sciences Innovation ETFLFSCETF
F/M Emerald Life Sciences Innovation ETF Logo

F/M Emerald Life Sciences Innovation ETF

ETF
🇺🇸LFSC•NASDAQ•Equity

Your view on LFSC

F/M Emerald Life Sciences Innovation ETF Logo

F/M Emerald Life Sciences Innovation ETF

ETFEmerald
🇺🇸LFSC•NASDAQ•Equity
AUM (USD)$125.00M
Expense Ratio0.79%
Holdings0

Sentiment

—

AUM (USD)

$125.00M

Expense Ratio

0.79%

Holdings

0

Sentiment

—
Fund Overview

Overview

What the fund invests in, who runs it, and what it costs.

F/M Emerald Life Sciences Innovation ETF (LFSC) is an Equity fund from Emerald, listed since 2024, with $125.0M in assets under management, a 0.79% expense ratio and a NAV of $45.28 USD.

Overview for F/M Emerald Life Sciences Innovation ETF

Fund Type
ETF
Fund Issuer
Emerald
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
October 30, 2024
Domicile
US
Website
emeraldetfs.com/lfsc
Fund Type
ETF
Fund Issuer
Emerald
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
October 30, 2024
Domicile
US
Website
emeraldetfs.com/lfsc
Fund Type
ETF
Fund Issuer
Emerald
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
October 30, 2024
Domicile
US
Website
emeraldetfs.com/lfsc

About this fund

LFSC seeks to invest in innovative life sciences companies that are expected to create value and long-term growth. The actively managed fund relies on a specialized and experienced team to research complex life sciences companies. It invests in US equity securities identified to …

Fund Data

Price Chart

Market price history and trading volume.

Key Facts

Cost, yield, size, and the fund's reference data.

Equity

Expense Ratio

0.79%

AUM

$125.00M

Fund Details

NAV$45.28 USD
Average Volume4.6K
Inception DateOctober 30, 2024
Asset ClassEquity
Fund IssuerEmerald
DomicileUS
ISINUS74933W2219
CUSIP74933W221
NAV CurrencyUSD

Expense Ratio

0.79%

Assets Under Management

$125.00M

NAV

$45.28 USD

Average Volume

4.6K

Inception Date

October 30, 2024

Asset Class

Equity

Fund Issuer

Emerald

Domicile

US

ISIN

US74933W2219

CUSIP

74933W221

NAV Currency

USD

Expense Ratio

0.79%

Assets Under Management

$125.00M

NAV

$45.28 USD

Average Volume

4.6K

Inception Date

October 30, 2024

Asset Class

Equity

Fund Issuer

Emerald

Domicile

US

ISIN

US74933W2219

CUSIP

74933W221

NAV Currency

USD

Data last updated: Nov 14, 2026, 08:10 AM

Sectors

How the fund's assets are split across sectors.

1 sectors
  • 1Healthcare
    100.0%

Top sector

Healthcare

Top weight

100.0%

Top 3 weight

100.0%

Holdings

The securities the fund owns, by weight.

37 positions
1REPLReplimune Group Inc
10.01%
2LIVNLivaNova PLC
8.10%
3COGTCogent Biosciences Inc
6.11%
4TVTXTravere Therapeutics Inc
5.84%
5UTHRUnited Therapeutics Corp
4.92%
6GHGuardant Health Inc
4.78%
7MIRMMirum Pharmaceuticals Inc
4.68%
8SYRESpyre Therapeutics Inc
4.27%
9BLLNBilliontoone Inc
4.08%
10TMDXTransMedics Group Inc
4.01%
11SVRASavara Inc
3.98%
12CYTKCytokinetics Inc
3.96%
13MANEVeraDermics Inc
3.85%
14ICUIICU Medical Inc
2.98%
15AXSMAxsome Therapeutics Inc
2.55%

Concentration

Total Holdings37
Top 10 Weight56.80%
Top HoldingREPL
Top Weight10.01%
1REPLReplimune Group Inc
10.01%
2LIVNLivaNova PLC
8.10%
3COGTCogent Biosciences Inc
6.11%
4TVTXTravere Therapeutics Inc
5.84%
5UTHRUnited Therapeutics Corp
4.92%
6GHGuardant Health Inc
4.78%
7MIRMMirum Pharmaceuticals Inc
4.68%
8SYRESpyre Therapeutics Inc
4.27%
9BLLNBilliontoone Inc
4.08%
10TMDXTransMedics Group Inc
4.01%
11SVRASavara Inc
3.98%
12CYTKCytokinetics Inc
3.96%
13MANEVeraDermics Inc
3.85%
14ICUIICU Medical Inc
2.98%
15AXSMAxsome Therapeutics Inc
2.55%

Total Holdings

37

Top 10 Weight

56.80%

Top Holding

REPL

Top Weight

10.01%

1REPLReplimune Group Inc
10.01%$12.03M
2LIVNLivaNova PLC
8.10%$9.73M
3COGTCogent Biosciences Inc
6.11%$7.35M
4TVTXTravere Therapeutics Inc
5.84%$7.02M
5UTHRUnited Therapeutics Corp
4.92%$5.91M
6GHGuardant Health Inc
4.78%$5.74M
7MIRMMirum Pharmaceuticals Inc
4.68%$5.63M
8SYRESpyre Therapeutics Inc
4.27%$5.14M
9BLLNBilliontoone Inc
4.08%$4.90M
10TMDXTransMedics Group Inc
4.01%$4.82M
11SVRASavara Inc
3.98%$4.78M
12CYTKCytokinetics Inc
3.96%$4.76M
13MANEVeraDermics Inc
3.85%$4.62M
14ICUIICU Medical Inc
2.98%$3.58M
15AXSMAxsome Therapeutics Inc
2.55%$3.07M

Total Holdings

37

Top 10 Weight

56.80%

Top Holding

REPL

Top Weight

10.01%

Peer Comparison

Comparables

Funds similar to this one.

Side by side on what an ETF is compared on9 funds
FundAsset classExpense ratioAssetsHoldings
LFSCF/M Emerald Life Sciences Innovation ETFThis fundEquity0.79%$125M0

Comparable funds

  • BCLOiShares BBB-B CLO Active ETFFixed Income0.45%$113M70
  • DEEDFirst Trust Securitized Plus ETFCore Investment Grade Bond0.66%$46M86
  • ICAPInfrastructure Capital Equity Income Fund ETFEquity2.47%$110M10
  • PPIAstoria Real Assets ETFAsset allocation0.57%$151M39
  • QARPXtrackers Russell 1000 US Quality at a Reasonable Price ETFEquity0.19%$80M414
  • RXLProShares - Ultra Health CareEquity1.08%$117M70
  • SURISimplify Propel Opportunities ETFEquity2.84%$70M19
  • TBFProShares - Short 20+ Year TreasuryFixed Income1.00%$115M11

More Emerald ETFs

  • SPITF/m Emerald Special Situations ETFEquity0.89%$32M0
Ownership & News

Fund Holders

Institutions that own shares of this fund.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for this company. Press releases and market coverage, newest first.

News

Latest Market News

News

Latest Market News